Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond

Nucleic Acids Research

Volumn 29, Issue 5, 2001, Pages 1034-1046

  Ding, Y ^a   Lawrence, C E ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA GLOBIN; DNA; MESSENGER RNA; RNA;

ALGORITHM; ARTICLE; CONTROLLED STUDY; DNA RNA HYBRIDIZATION; DRUG TARGETING; ENERGY; GENE FUNCTION; IN VITRO STUDY; INFORMATION; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROTEIN RNA BINDING; RABBIT; RNA HYBRIDIZATION; RNA SEQUENCE; RNA STRUCTURE; RNA TRANSLATION; SAMPLING; SCREENING; STATISTICS; TECHNIQUE;

ORYCTOLAGUS CUNICULUS;

EID: 0035283171     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.5.1034     Document Type: Article

References (69)

1. On finding all suboptimal foldings of an RNA molecule
2. The use of dynamic programming algorithms in RNA secondary structure prediction
3. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information
4. The equilibrium partition function and base pair binding probabilities for RNA secondary structure
5. Fast folding and comparison of RNA secondary structures
6. A Bayesian statistical algorithm for RNA secondary structure prediction
7. An RNA folding rule
8. A kinetic approach to the prediction of RNA secondary structures
9. A kinetic model of RNA folding
10. The computer simulation of RNA folding pathways using a genetic algorithm
11. The loop E-loop D region of Escherichia coli 5S rRNA: The solution structure reveals an unusual loop that may be important for binding ribosomal proteins
12. Ribonuclease P RNA: Models of the 15/16 bulge from Escherichia coli and the P15 stem loop of Bacillus subtilis
13. An RNA internal loop acts as a hinge to facilitate ribozyme folding and catalysis
14. Mapping of a protein-RNA kissing hairpin interface: Rom and Tar-Tar
15. NMR structure of a bacteriophage T4 RNA hairpin involved in translational repression
16. RNA structure in solution
17. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide
18. Do natural antisense transcripts make sense in eukaryote?
19. An overview of progress in antisense therapeutics
20. Antisense oligonucleotides: A systematic high-throughput approach to target validation and gene function determination
21. Implication of RNA structure on antisense oligonucleotide hybridization kinetics
22. Effects of RNA secondary structure on cellular antisense activity
23. A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: Correlation with an intracellular pattern and known RNA structures
24. Selecting effective antisense reagents on combinatorial oligonucleotide arrays
25. Determining the influence of structure on hybridization using oligonucleotide arrays
26. Structural basis for binding of the plasmid Collb-P9 antisense Inc RNA to its target RNA with the 5′-rUUGGCG-3′ motif in the loop sequence
27. Predicting antisense oligonucleotide inhibitory efficacy: A computational approach using histograms and thermodynamic indices
28. An RNA secondary structure workbench
29. Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1
30. Stability of RNA stem-loop structure and distribution of non-random structure in the human immunodeficiency virus (HIV-1)
31. Rules for ribozymes
32. Computational approaches to the identification of ribozyme target sites
33. Expanded sequence dependence of thermodynamic parameters provides robust prediction of RNA secondary structure
34. Thermodynamic parameters for an expanded nearest-neighbor model for formation of RNA duplexes with Watson-Crick base pairs
35. Compilation of tRNA sequences and sequences of tRNA genes
36. Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding
37. 5S rRNA data bank
38. Collection of small subunit (16S- and 16S-like) ribosomal RNA structures
39. The ribonuclease P database
40. Representation of the secondary and tertiary structure of group I introns
41. A comparative database of group I intron structures
42. A comparison of thermodynamic foldings with comparatively derived structures of 16S and 16S-like rRNAs
43. 'Well-determined' regions in RNA secondary structure prediction: Analysis of small subunit ribosomal RNA
44. Enzymatic amplification of translation inhibition of rabbit beta-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents
45. Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides
46. Selecting optimal antisense reagents
47. Complete suboptimal folding of RNA and the stability of secondary structures
48. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism
49. Basic principles of using antisense oligonucleotides in vivo
50. Progress in antisense technology: The end of the beginning
51. Two problems in antisense biotechnology: In vitro delivery and the design of antisense experiments
52. Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries
53. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries
54. Discovering antisense reagents by hybridization of RNA to oligonucleotide arrays
55. Prediction of antisense oligonucleotide efficacy by in vitro methods
56. Predicting oligonucleotide affinity to nucleic acid targets
57. Antisense oligonucleotides as a tool for gene functionalization and target validation
58. Oligonucleotide-based inhibition of embryonic gene expression
59. Shortcuts from gene sequence to function
60. Drug discovery in the next millennium
61. Exploring the new world of the genome with DNA microarrays
62. Expression monitoring by hybridization to high-density oligonucleotide arrays
63. Cluster analysis and display of genome-wide expression patterns
64. Genome II: The next frontier
65. Drug firms to create public database of genetic mutations
66. The use of single-nucleotide polymorphism maps in pharmacogenomics
67. The essence of SNPs
68. Keeping the biotechnology of antisense in context
69. Molecular interactions on microarrays